Widening use of dexamethasone implant for the treatment of macular edema

Sustained-release intravitreal 0.7 mg dexamethasone (DEX) implant is approved in Europe for the treatment of macular edema related to diabetic retinopathy, branch retinal vein occlusion, central retinal vein occlusion, and non-infectious uveitis. The implant is formulated in a biodegradable copolyme...

Descripción completa

Detalles Bibliográficos
Autores principales: Bonfiglio, Vincenza, Reibaldi, Michele, Fallico, Matteo, Russo, Andrea, Pizzo, Alessandra, Fichera, Stefano, Rapisarda, Carlo, Macchi, Iacopo, Avitabile, Teresio, Longo, Antonio
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2017
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566324/
https://www.ncbi.nlm.nih.gov/pubmed/28860707
http://dx.doi.org/10.2147/DDDT.S138922

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5566324/
https://www.ncbi.nlm.nih.gov/pubmed/28860707
http://dx.doi.org/10.2147/DDDT.S138922

Ejemplares similares